|
US4352883A
(en)
|
1979-03-28 |
1982-10-05 |
Damon Corporation |
Encapsulation of biological material
|
|
US4353888A
(en)
|
1980-12-23 |
1982-10-12 |
Sefton Michael V |
Encapsulation of live animal cells
|
|
US4569967A
(en)
|
1983-10-24 |
1986-02-11 |
The Salk Institute For Biological Studies |
Synthesis of N-substituted peptide amides
|
|
US4883666A
(en)
|
1987-04-29 |
1989-11-28 |
Massachusetts Institute Of Technology |
Controlled drug delivery system for treatment of neural disorders
|
|
US5158881A
(en)
|
1987-11-17 |
1992-10-27 |
Brown University Research Foundation |
Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
|
|
US5283187A
(en)
|
1987-11-17 |
1994-02-01 |
Brown University Research Foundation |
Cell culture-containing tubular capsule produced by co-extrusion
|
|
DE3829766A1
(de)
|
1988-09-01 |
1990-03-22 |
Akzo Gmbh |
Verfahren zur herstellung von membranen
|
|
DE3829752A1
(de)
|
1988-09-01 |
1990-03-22 |
Akzo Gmbh |
Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration
|
|
US5082670A
(en)
|
1988-12-15 |
1992-01-21 |
The Regents Of The University Of California |
Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
|
|
US5084350A
(en)
|
1990-02-16 |
1992-01-28 |
The Royal Institution For The Advance Of Learning (Mcgill University) |
Method for encapsulating biologically active material including cells
|
|
US5618531A
(en)
|
1990-10-19 |
1997-04-08 |
New York University |
Method for increasing the viability of cells which are administered to the brain or spinal cord
|
|
HK1001832A1
(en)
|
1991-04-25 |
1998-07-10 |
Brown University Research Foundation |
Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
|
|
US5854217A
(en)
|
1992-09-28 |
1998-12-29 |
Bearsden Bio, Inc. |
Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
|
|
ATE190633T1
(de)
|
1993-04-27 |
2000-04-15 |
Cytotherapeutics Inc |
Membran aus einem acrylnitrilpolymer
|
|
CA2166116A1
(en)
|
1993-06-23 |
1995-01-12 |
John F. Mills |
Method and apparatus for sealing implantable, membrane encapsulation devices
|
|
US5595972A
(en)
*
|
1993-06-29 |
1997-01-21 |
University Of Utah Research Foundation |
Conotoxin peptides
|
|
US5432155A
(en)
*
|
1993-06-29 |
1995-07-11 |
The Salk Institute For Biological Studies |
Conotoxins I
|
|
US5514774A
(en)
*
|
1993-06-29 |
1996-05-07 |
University Of Utah Research Foundation |
Conotoxin peptides
|
|
JP4098355B2
(ja)
|
1993-08-12 |
2008-06-11 |
ニューロテック ユーエスエー， インコーポレイテッド |
遺伝的に改変された細胞を含む生体適合性免疫隔離カプセル
|
|
US5550050A
(en)
|
1994-04-15 |
1996-08-27 |
Cytotherapeutics, Inc. |
Method for implanting encapsulated cells in a host
|
|
US5834029A
(en)
|
1994-07-20 |
1998-11-10 |
Cytotherapeutics, Inc. |
Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
|
|
US5853717A
(en)
|
1994-07-20 |
1998-12-29 |
Cytotherapeutics, Inc. |
Methods and compositions of growth control for cells encapsulated within bioartificial organs
|
|
US5837234A
(en)
|
1995-06-07 |
1998-11-17 |
Cytotherapeutics, Inc. |
Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane
|
|
IN181898B
(enExample)
|
1995-06-07 |
1998-10-24 |
Cytotherapeutics Inc |
|
|
AU7204996A
(en)
|
1995-10-02 |
1997-04-28 |
Cytotherapeutics, Inc. |
Method for treating amyotrophic lateral sclerosis
|
|
US5844077A
(en)
|
1997-04-28 |
1998-12-01 |
Cytotherapeutics, Inc. |
Use of conantokins for producing analgesia or for neuroprotection
|
|
US5866682A
(en)
*
|
1997-05-15 |
1999-02-02 |
University Of Utah Research Foundation |
Conopeptides AuIA, AuIB and AuIC
|
|
AU2091799A
(en)
*
|
1997-12-31 |
1999-07-19 |
University Of Utah Research Foundation |
Uses of alpha-conotoxin peptides
|
|
AUPP589598A0
(en)
|
1998-09-14 |
1998-10-08 |
University Of Queensland, The |
Novel peptides
|
|
JP2003525582A
(ja)
*
|
1999-01-22 |
2003-09-02 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション |
アルファ−コノトキシンペプチド
|
|
US6767896B1
(en)
*
|
1999-01-29 |
2004-07-27 |
Cognetix, Inc. |
Conotoxin peptides
|
|
US6797808B1
(en)
*
|
1999-01-29 |
2004-09-28 |
University Of Utah Research Foundation |
α-conotoxin peptides
|
|
WO2000046371A1
(en)
*
|
1999-02-04 |
2000-08-10 |
University Of Utah Research Foundation |
Tau-conotoxin peptides
|
|
US6762165B2
(en)
*
|
1999-12-30 |
2004-07-13 |
University Of Utah Research Foundation |
O-superfamily conotoxin peptides
|
|
AU2001271657A1
(en)
*
|
2000-06-30 |
2002-01-14 |
Cognetix, Inc. |
I-superfamily conotoxins
|
|
JP2004537253A
(ja)
*
|
2000-07-21 |
2004-12-16 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション |
ミュー−コノペプチド
|
|
WO2002064740A2
(en)
|
2001-02-09 |
2002-08-22 |
Cognetix, Inc. |
Cone snail peptides
|
|
US7387997B2
(en)
*
|
2004-11-09 |
2008-06-17 |
University Of Utah |
α-conotoxin MII analogues
|
|
CA2566832A1
(en)
*
|
2006-04-13 |
2007-10-13 |
The University Of Queensland |
Cyclised alpha-conotoxin peptides
|
|
US9284358B2
(en)
*
|
2006-07-18 |
2016-03-15 |
University Of Utah Research Foundation |
Conotoxin peptides
|
|
JP5558817B2
(ja)
*
|
2006-07-18 |
2014-07-23 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション |
痛みの処置方法および鎮痛化合物のスクリーニング方法
|
|
US8765677B2
(en)
*
|
2009-09-21 |
2014-07-01 |
The University Of Queensland |
Omega conotoxin peptides
|
|
JP6336979B2
(ja)
*
|
2012-08-07 |
2018-06-06 |
ハイナン ユニバーシティ |
α−コノトキシンペプチド、その医薬組成物及びそれらの使用
|